Trademark Overview
On Thursday, March 2, 2023, a trademark application was filed for CAPDRIVE with the United States Patent and Trademark Office. The USPTO has given the CAPDRIVE trademark a serial number of 79370455. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 19, 2024. This trademark is owned by Skyline Therapeutics (Shanghai) Co.,Ltd.. The CAPDRIVE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Stem cells for medical purposes; biochemical medicine; biological preparations for medical purposes; biological tissue cultures for medical purposes; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemico-pharmaceutical preparations; drugs for medical purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the central nervous system; ophthalmological preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cardiovascular agents for medical purposes; cellular function activating agents for medical purposes; pharmaceutical products for the prevention and treatment of cancer
Scientific research and development; scientific research; technological research; biological research; clinical trials; medical research; pharmaceutical research services; research on the subject of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; structural and functional analysis of genomes; biotechnology research; analysis of the mode of action of chemical combinations on animals; research and development services in the field of antibodies; genetic testing for scientific research purposes; biological research and analysis; pharmaceutical drug development services; DNA screening for scientific research purposes; medical research; testing of pharmaceuticals; biomedical research services